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their role has been under-studied. This study examined cytokine responses in KCs following infection with
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vaccine strains, yet wild-type YFV induced a prominent and prolonged pro-inﬂammatory cytokine response
(IL-8, TNF-α and RANTES/CCL5) with little control by a major anti-inﬂammatory cytokine (IL-10). This
response was signiﬁcantly reduced in vaccine strain infections. These data suggest that a differentially
regulated infection in KCs may play a critical role in development of disease.cility, 8200 Research Plaza, Ft.
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Yellow fever virus (YFV) (family Flaviviridae, genus Flavivirus) is
the causative agent of yellow fever (YF), an often fatal viral hemor-
rhagic fever. YFV infection carries a 20–50% mortality rate and it is
estimated that approximately 30,000 deaths occur annually due to
this disease (World Health Organization). The 17-D virus, is the live-
attenuated vaccine strain of YFV that is typically very well-received by
the vaccinee and confers protection for at least 10 years following a
single inoculation. 17-D virus has been used for more than 70 years
with over 500 million doses administered and with relatively few
serious adverse events (Monath et al., 2010). However, as techniques
for detecting and reporting serious adverse events improve, an
increasing number of YF vaccine associated serious adverse events
(YFV-SAEs) have been reported.
YFV is highly hepatotropic, sometimes involving as much as 80% of
hepatocytes in infected humans (Klotz and Belt, 1930). YFV infection
results in ﬁve distinct liver pathologies: lesions of the midzone,
steatosis, severe inﬂammation with disproportionate inﬂammatory
cell inﬁltrate, eosinophilic degeneration of hepatocytes and Kupffer
cells (Councilman bodies), and upon resolution of infection, a
complete return to normal histology (Monath and Barrett, 2003).Even though these pathologies have been well characterized little is
known about mechanisms associated with their development.
Kupffer cells (KCs) are resident liver macrophages responsible for
detecting pathogens and activating local immune responses. KCs’ role
in disease development appears to be critical as evidence suggests
they are the ﬁrst cells to become infected when YFV enters the liver
(Bearcroft, 1957; Klotz and Belt, 1930; Tigertt et al., 1960). Little is
known about the pathogenesis of YFV in KCs; however, because of
their involvement in early infection and potential immune activation,
we hypothesize that these cells play a signiﬁcant role in YFV
pathogenesis. This study compared viral growth kinetics and cytokine
responses in KCs following infection with either wild-type (Asibi
virus) or vaccine (17-D virus) strains of YFV.Wild-type YFVwas found
to replicate more efﬁciently and to induce a more profound pro-
inﬂammatory response in KCs compared to infection with the 17-D
vaccine strain. These data suggest that poor regulation of infection by
KCs may be a critical component for development of severe disease.
Results
Kupffer cells increase cell surface markers CD14, CD86 and HLA-DR after
IL-6 stimulation
Kupffer cells are professional immune cells within the liver and
their activation by cytokine signals and pathogenic antigens are
critical for inducing protective responses. Kupffer cells, as other
macrophages, can become activated by pathogen-associated
189S.E. Woodson et al. / Virology 412 (2011) 188–195membrane proteins (PAMPs, such as LPS) via toll-like receptors or
primed by exogenous cytokines (Bilzer et al., 2006; ten Hagen et al.,
1998). Some studies have reported early and prominent serum
increases of IL-6 in YFV vaccinees as well as from other cells types,
such as endothelial cells, during wild-type virus infection (Khaiboul-
lina et al., 2005; van der Beek et al., 2002; Verschuur et al., 2004). To
determine if early exogenous increases in IL-6 would modulate
activation and subsequent response of KCs to infection with Asibi and
17-D viruses, unstimulated and IL-6 pre-stimulated primary KCs were
used in this study. Prior to viral infection, unstimulated and IL-6 pre-
stimulated KCs were tested by ﬂow cytometry for cell surface markers
CD14, CD86 and HLA-DR (common macrophage markers) to assess
the purity of each population and activation state after IL-6
stimulation. Using these markers we were able to conclude that
both populations were N90% pure (data not shown). Compared to
unstimulated KCs, all three cell surface markers were increased after
IL-6 stimulation for 5 days. CD14 and HLA-DR increased by 2.9- and
2.4-fold, respectively, while CD86 increased to a lesser extent at 1.6-
fold (data not shown). Kupffer cell surface marker up-regulation
suggests these cells become activated in response to exogenous IL-6
stimulation.
Asibi and 17-D viruses replicate efﬁciently in Kupffer cells
Kupffer cells appear to be the ﬁrst cells infected upon wild-type
YFV invasion of the liver; however, no data are available to determine
if the vaccine strain, 17-D virus, is capable of infecting or replicating
efﬁciently in these cells. We wanted to determine if KCs support
infection and replication of both Asibi virus (wild-type) and 17-D
virus (vaccine strain) and if replication efﬁciency was modulated by
IL-6 pre-stimulation of KCs. Fig. 1A demonstrates that Asibi virus
replicates to signiﬁcantly (pb0.05) higher titers than 17-D virus
(except at 24 h post-infection) in unstimulated KCs and is detectable
through 144 h post-infection. IL-6 pre-stimulation improved the
replication efﬁciency of Asibi virus, but not 17-D virus (Fig. 1B),
resulting in signiﬁcantly higher titers of Asibi virus. In contrast,
replication of 17-D virus was not affected by IL-6 pre-stimulation of
KCs (Fig. 1 A and B). IL-6 pre-stimulated KCs also had sustained high
titers of Asibi virus, lasting through 120 h post-infection, whereas
unstimulated KCs only had a short-lived single peak titer.
Cell viabilitywas also affected byYFV infectionwhereunstimulated
KCs infected with either Asibi virus and 17-D virus had 32% and 47%Time Post-Infection (Hours)
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Fig. 1. Wild-type and vaccine strain YFV replication kinetics in unstimulated and IL-6 p
unstimulated (A) and IL-6 pre-stimulated (B) Kupffer cells by immuno-focus assay. Asibi viru
both KC groups. IL-6 pre-stimulation of KCs does not appear to effect 17-D virus replicationviability at 144 h post-infection, respectively. IL-6 pre-stimulation of
KCs improved viability of Asibi virus infected cells with 52% viable at
144 h post-infection. In contrast, IL-6 pre-stimulation did not
signiﬁcantly enhance cell survival (49% live at 144 h post-infection)
after 17-D virus infection.
Asibi virus infection elicits strong pro- and anti-inﬂammatory responses
from unstimulated Kupffer cells
One of the most important activities of KCs is to delineate between
self and pathogenic antigens. An example of KC regulation of liver
homeostasis is through release of anti- and pro-inﬂammatory
cytokines. For this study, we chose to investigate a small subset of
cytokines, IL-8, IL-10, RANTES/CCL5 and TNF-α, which previous
publications suggest may be important in the development or
progression of disease during YFV infections (Bae et al., 2008; Belsher
et al., 2007; Doblas et al., 2006; Gaucher et al., 2008; Hacker et al.,
1998; Khaiboullina et al., 2005; ter Meulen et al., 2004; van der Beek
et al., 2002). Cytokine responses were measured from unstimulated
KCs over a 6-day period following mock infection or infection with
either Asibi virus or 17-D virus.
In general, Asibi virus infection of unstimulated KCs resulted in
overall higher cytokine expression, at both the transcriptional and
translational level when compared to either mock or 17-D virus
infected cells (Fig. 2). IL-8 cytokine expression was up-regulated early
during infection (48 h post-infection), while TNF-α, RANTES/CCL5
and IL-10 were all up-regulated later (96 h post-infection) (Fig. 2A–
D). Gene expression for IL-8, TNF, RANTES/CCL5 and IL-10 corre-
sponded reasonably well with few exceptions to cytokine expression
(Fig. 2A–D). Gene expression for TNF was up-regulated extensively in
the 17-D virus infected group early during infection without an
increase in TNF-α release. However, this gene encodes for the whole
TNF superfamily and may not directly represent gene expression
speciﬁc to TNF-α production.
IL-6 pre-stimulation of Kupffer cells modulates pro- and anti-inﬂammatory
cytokine responses to infection with Asibi virus and 17-D virus
IL-6 pre-stimulated KCs were also tested for the expression
proﬁles of IL-8, TNF-α, RANTES/CCL5 and IL-10 post-infection with
Asibi virus, 17-D virus or mock (control). IL-8, TNF-α and RANTES/
CCL5 remained signiﬁcantly higher (pb0.05) from Asibi virus infectedTime Post-Infection (Hours)
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B
re-stimulated Kupffer cells. Asibi virus and 17-D virus replication was evaluated in
s (○) replicates to signiﬁcantly (* indicates pb0.05) higher titers than 17-D virus (●) in
. Supernatants for each time point were harvested from separate wells.
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191S.E. Woodson et al. / Virology 412 (2011) 188–195KCs in comparison to 17-D infected cells (Fig. 3A–C). We detected a
signiﬁcantly (pb0.05) up-regulated expression level of TNF-α and
RANTES/CCL5 in the IL-6 pre-stimulated KCs after infection, regardless
of the infecting virus. In contrast to unstimulated cells, a temporal
difference in release of IL-8 was observed. At early time points post-
infection release of IL-8 was down-regulated, while at later stages of
the infection an up-regulation was detectable. We also observed that
IL-10 cytokine release was signiﬁcantly down-regulated from both
YFV infections (Fig. 3D), but overall IL-10 concentrations were higher
following 17-D virus infection. Gene expression of IL-8, TNF-α,
RANTES/CCL5 and IL-10 did not appear to be greatly up- or down-
regulated in IL-6 pre-stimulated KCs when compared to unstimulated
KCs. This result may indicate that IL-6 pre-stimulation of KCs (and
subsequent activation) results in more efﬁcient translation or release
of these cytokines.
Discussion
KCs are one of the three principal cell types within the liver
along with hepatocytes and endothelial cells. As a specialized
macrophage the principal roles of Kupffer cells are phagocytosis,
antigen presentation and recruitment of additional immune cells to
sites of inﬂammation in the liver. KCs are found lining the sinusoids
and have direct contact with hepatocytes. Previous studies indicate
that KCs are the ﬁrst to become infected during YFV infection, and
because of their function, may be an important modulator of the
immune response in the liver (Bearcroft, 1957; Klotz and Belt,
1930; Smetana, 1962; Tigertt et al., 1960). The response of KCs to
infection is vital towards maintaining overall liver health and any
inhibition or exacerbation of their response by a pathogen could
lead to more severe infection and, given the association of the liver
with the vascular system via the hepatic vein, potentially more
efﬁcient dissemination of the pathogen.
In this study we wanted to investigate whether the response of
KCs to infection with wild-type or vaccine strains of YFV was
signiﬁcantly different to determine if KCs might play a key role in
the development of disease. Further, we wanted to evaluate whether
the infection of KCs could be exacerbated by IL-6. Previous works have
indicated that wild-type infection and vaccination induced a
signiﬁcant release of IL-6 in patients (Belsher et al., 2007; Doblas et
al., 2006; ter Meulen et al., 2004; van der Beek et al., 2002; Verschuur
et al., 2004). Our results showed that primary KCs allow for more
efﬁcient replication of wild-type YFV than the vaccine strain and that
this difference is ampliﬁed in the presence of IL-6. Further, we have
shown that wild-type YFV infection of KCs stimulates a signiﬁcantly
more pronounced inﬂammatory cytokine response than infection
with the vaccine strain. These data demonstrate that KCs may be
unable to regulate infection bywild-type YFV and the subsequent pro-
inﬂammatory responsemay play a signiﬁcant role in the development
of severe disease.
The cytokine expression proﬁle of three out of four key
inﬂammatory mediators was essentially the same in cells that were
either naïve or pre-stimulated with IL-6 prior to infection. However,
differential regulation was demonstrated for IL-10 between naïve and
IL-6 pre-stimulated cells following infection with wild-type YFV. The
primary function of IL-10 is anti-inﬂammatory in nature and has been
shown to be an important signaling molecule between natural killer
cells and KCs (Tu et al., 2008; Zhang et al., 2010). Activation of TLR3 by
dsRNA (such as YFV replication intermediates) stimulates down-
regulation of IL-10 and up-regulation of pro-inﬂammatory cytokinesFig. 2. Cytokine and gene expression from YFV infected unstimulated Kupffer cells. Unstimu
(black bars) infected and subsequent cytokine (left side) and cytokine gene expression (rig
TNF-α (B), RANTES/CCL5 (C) and IL-10 (D) all had similar proﬁles of release that corresponde
concentrations of cytokines (‡, centered over time point, indicates pb0.05) and gene expr
infected cells. All data presented here is the average of triplicate measurements. Gene expr(Tu et al., 2008). We did not observe this “normal” response in KCs
infected with Asibi virus. IL-10 transcriptional and translational
expression levels were signiﬁcantly higher in KCs infected with
wild-type Asibi virus than in naïve cells infected with the vaccine
strain 17-D, suggesting an active effort in regulating the host
response. High gene expression of IL-10 has also been observed in
the livers of Jimenez strain (hamster adapted wild-type YFV) infected
Syrian golden hamsters (Li et al., 2008). We also found that pre-
stimulation with IL-6 mitigated the production and release of IL-10 at
the level of transcription in Asibi infected cells, indicating that this
virus, in the presence of IL-6, could effectively block the regulatory
role of IL-10. Such a situation could give rise to an unrestricted
inﬂammatory response resulting in the observed characteristic
development of cellular apoptosis in the liver of YF patients. The
activity of IL-10 in regulating the host immune response may be a key
element in the differential response between infections with wild-
type or vaccine strains of YFV.
Kupffer cells, like circulating macrophages, can also produce a
number of pro-inﬂammatory cytokines including IL-8, TNF-α and
RANTES/CCL5. We found that all three of these cytokines were
signiﬁcantly up-regulated in Asibi virus infected KCs regardless of
their IL-6 pre-stimulation status. Release of all three cytokines was
generally increased in 17-D infected cells, but not to the magnitude
observed for cells infectedwithwild-type Asibi virus. Gene expression
data largely mimicked protein release indicating that cytokine
production was regulated predominately at the transcriptional level.
Analysis of IL-6 mRNA indicated that Asibi virus infection also up-
regulated expression of IL-6 to a level greater than in 17-D infection
(data not shown), perhaps indicating the potential for deleterious
autocrine signaling.
The up-regulation of IL-8, TNF-α and RANTES/CCL5 in KCs
indicates the activation of a pro-inﬂammatory response following
infection with YFV. TNF-α is well known to be associated with
activation of NF-κB which regulates IL-6 and IL-8 expression (Roe-
buck, 1999; Schutze et al., 1995; Vanden Berghe et al., 2000). TNF-α
also has pro-apoptotic properties (Tacke et al., 2009). Subsequently,
very high concentrations of TNF-α from KCs could be cytotoxic to
surrounding hepatocytes, whereas lower levels can induce a pro-
proliferative state for these cells (Dong et al., 2007; Smedsrod et al.,
2009). Since Asibi virus infection induced signiﬁcantly higher
concentrations of TNF-α than 17-D virus, this may indicate that part
of the necrosis and apoptosis seen in hepatocytes during late stage
disease is due to an elevated TNF-α level within the liver. TNF-α
expression was also observed to be elevated during early and late
stage with a decrease at mid-stage disease in livers from the YFV
Syrian golden hamster model (Li et al., 2008). Since 17-D virus is
attenuated and does not appear to induce a strong pro-inﬂammatory
response, it is possible that the amount of TNF-α produced is
sufﬁcient to control viral replication.
Expression of IL-8 was also elevated in wild-type Asibi virus
infected KCs relative to both mock and 17-D virus infected cells. Like
IL-6, IL-8 is a major component of the pro-inﬂammatory response
whose expression is also regulated through NF-κB (Roebuck, 1999).
IL-8 is readily produced from KCs, but can also result in a prolonged
state of inﬂammation (Szabo et al., 2007). IL-8 can activate
neutrophils and cause them to migrate to areas of inﬂammation
(Harada et al., 1994). The presence of high levels of IL-8 suggests that
wild-type, and to a lesser extent vaccine strain, YFV infection would
induce signiﬁcant neutrophil inﬁltration into the liver, however this
has not been observed in post-mortem examinations (Klotz and Belt,lated Kupffer cells were either mock (gray bars), Asibi virus (white bars) or 17-D virus
ht side) were measured. Pro-inﬂammatory and anti-inﬂammatory cytokines IL-8 (A),
d reasonably well with gene expression. Asibi virus infected KCs had signiﬁcantly higher
ession (*, centered over time point, indicates pb0.05) when compared to 17-D virus
ession data is presented as fold change versus control.
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193S.E. Woodson et al. / Virology 412 (2011) 188–1951930; Smetana, 1962; Tigertt et al., 1960). The mechanism behind the
disproportionate levels of IL-8 and neutrophil migration remains to be
characterized.
RANTES/CCL5 was also up-regulated extensively in Asibi virus
infected KCs when compared to mock and 17-D virus infected cells.
RANTES/CCL5 is a chemotactic agent for T cells and also plays a role in
activation of NK cells. Previous studies have shown that YFV infected
monkeys have some lymphocyte inﬁltration before the ﬁnal 24-hours
of life in the liver (Monath et al., 1981). In contrast, YFV infected
humans (at post-mortem examination) have very little if any
lymphocyte inﬁltration in the liver (Klotz and Belt, 1930). These
results, as with the IL-8, suggest the potential for signiﬁcant
lymphocyte inﬁltration into the liver; however, the lack of supporting
pathology data suggests the presence of an as yet unidentiﬁed
regulatory processes.
Clearly the interaction between multiple cell types, particularly
KCs and hepatocytes, plays a vital role in the regulation of infection
and the development of disease. In this study we focused on one
component of this interaction in order to identify a speciﬁc host
response that may be vital for determining whether an infection is
controlled. In this study we have shown that three major pro-
inﬂammatory cytokines are up-regulated in YFV infection of KCs, but
that the wild-type Asibi virus stimulates a more profound response
from these cells than does infection with the vaccine strain 17-D. This
response may be correlated to the replication efﬁciency of Asibi virus
in KCs as the infectious titer was markedly higher than that of 17-D
virus. In addition, we found that IL-6 stimulated KCs had signiﬁcantly
attenuated IL-10 gene expression and subsequent protein release
after Asibi virus infection. This effect was not seen in 17-D virus
infected cells. This ﬁnding suggests that Asibi virus, in the presence of
IL-6, may speciﬁcally block production of IL-10 potentially leading to
an un-regulated pro-inﬂammatory response. Such a scenario could
lead to the pathology seen in the liver of people who succumb to YFV
infections. Future studies of the hepatocyte response to infection with
YFV will provide additional information regarding the interactions
between these two key components of the liver.
Materials and methods
Cells
Kupffer cells (KCs) were purchased from Celsis (Baltimore, MD).
Due to very limited availability and highly speciﬁc donor require-
ments, KCs used in this experiment were from a single donor. The
donor was an apparently healthy 17 year old white male with no
obvious signs of liver disease and was negative for hepatitis C virus,
hepatitis B virus, human immunodeﬁciency virus, Epstein–Barr virus
and positive for cytomegalovirus. Kupffer cells arrived at a plated
density of 106 cells/well in 24-well culture plates. This cell density was
chosen by Celsis due to the small size of KCs and their standard
protocol of plating cells to N70% conﬂuency. KCs were maintained in
the recommended media available from Celsis, InVitroGRO CP
(plating) medium custom made with heat inactivated newborn calf
serum and supplemented upon arrival with Torpedo antibiotic mix
(Celsis). KCs media was changed upon arrival and were allowed to
acclimate for 24-hours before stimulation treatments (described
below). Prior to manipulation, cell density was determined (using
trypan blue exclusion) in one representative well.Fig. 3. Cytokine and gene expression from YFV infected IL-6 pre-stimulated Kupffer cells. Cyto
stimulated Kupffer cells that were either mock (gray bars), Asibi virus (white bars) or 17-D v
CCL5 (C) all had similar proﬁles of release and concentrations were elevated compared
concentrations of pro-inﬂammatory cytokines and gene expression when compared to 17-D
was detected in higher concentrations from 17-D virus infected samples but was overall d
between Asibi virus and 17-D virus infected samples are noted by ‡ for cytokine expressio
signiﬁcance occurred. All data presented here is the average of triplicate measurements. GeVERO-E6 cells were used for generation of virus stocks and
titration assays. VERO-E6 cells were maintained in complete growth
media (modiﬁed Eagle's medium containing 2 mM L-glutamine and
Earle's balanced salts (Hyclone) supplemented with 10% fetal bovine
serum (FBS) (Hyclone), 1% of 100× non-essential amino acids, and 1%
of 100 mM sodium pyruvate (Sigma)).
IL-6 pre-stimulation of Kupffer cells
Half of the KCs described here were treated with 5 ng/mL of
recombinant human IL-6 (R&D Systems) for 5 days prior to infection.
The remaining half of KCs were unstimulated. IL-6 pre-stimulated and
unstimulated experiments were run concurrently.
Flow cytometry
Kupffer cells (KCs) were stained for CD14, CD86 and HLA-DR and
tested on a BD Biosciences FACSCanto II to determine population
purity, quality, and activation state. Tests on populations were
performed before infection. Antibodies used were PerCP-Cy 5.5
mouse anti-human CD14 (BD Pharmingen), PerCP-Cy 5.5 mouse
IgG2a K isotype control, allophycocyanin anti-human HLA-DR,
allophycocyanin mouse IgG2b isotype control (eBioscience), allophy-
cocyanin mouse anti-human CD86 and allophycocyanin mouse IgG1
isotype control (Invitrogen).
Virus
YFV-Asibi strain was used as the wild-type virus and was provided
by Dr. Robert Tesh (University of Texas Medical Branch, Galveston TX
andWorld Reference Collection for Emerging Viruses and Arboviruses
[WRCEVA]). The vaccine strain, YFV 17-D-204, was derived from the
17-D infectious clone (Rice et al., 1989) and was provided by Dr. Alan
Barrett (University of Texas Medical Branch, Galveston TX). Asibi and
17-D virus working stocks were grown in VERO-E6 cells (ATCC,
CRL1586) and harvested 4 days post-infection or when cytopathic
effects were ﬁrst visible. Viral titers were measured by immuno-focus
assays.
Immuno-focus assays
Immuno-focus assays were used to determine titers of viral
working stocks and in growth kinetics assays where each time point
was evaluated in triplicate. Brieﬂy VERO-E6 cells were infected with
serial dilutions (10−1 to 10−6 in 100 μL) of individual samples for 1 h
at 37 °C/5% CO2 with occasional rocking. Cells were washed 3× with
PBS before addition of 1 mL of 1:1 ratio of 2% agarose (ISC
BioExpress): 2× MEM (Invitrogen) supplemented with 4% bovine
growth serum (BGS) (Hyclone), 2% of 100× non-essential amino
acids, and 2% of 100 mM sodium pyruvate (Sigma) as the overlay.
Plates were allowed to incubate at 37 °C/ 5% CO2 for 4 days before
being ﬁxed with 10% formalin for 1 h at room temperature. After
ﬁxation, the agarose plugs were removed and the plates were
incubated with 70% ethanol for 20 min at room temperature. The
ethanol was removed and the plates were washed once with PBS
before addition of primary antibody. Mouse hyper-immune ascitic
ﬂuid raised against YFV-Asibi (WRCEVA) was used as the primary
antibody. The primary antibody was diluted 1:500 in PBS containingkine (left side) and cytokine gene expression (right side) weremeasured from IL-6 pre-
irus (black bars) infected. Pro-inﬂammatory cytokines IL-8 (A), TNF-α (B) and RANTES/
to the unstimulated group (Fig. 2). Asibi virus infected KCs had signiﬁcantly higher
virus infected cells. Anti-inﬂammatory cytokine IL-10 (D) release and gene expression
ecreased when compared to the unstimulated group. Signiﬁcant differences, pb0.05,
n and * for gene expression which are centered over the time post-infection in which
ne expression data is presented as fold change versus control.
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was allowed to bind overnight at room temperature with constant
rocking. Primary antibody was removed, plates washed once with PBS
then goat anti-mouse IgG-HRP (Dako) secondary antibody diluted
1:500 in PBS containing 1% BGS was added. The secondary antibody
was allowed to incubate at room temperature for 4–5 h with constant
rocking. Plates were then washed thoroughly and immuno-focus
units were visualized by addition of AEC substrate chromogen (Dako)
for 15–20 min at room temperature. The reaction was stopped by
washing with water.
Viral growth kinetics
KCs were infected with either Asibi virus or 17-D virus at a
multiplicity of infection (MOI) of 0.1 diluted in complete medium.
Control KCs were mock-infected with complete media. Brieﬂy, KCs
were infected with 100 μL of viral suspension for 1 h at 37 °C/5% CO2
with occasional rocking. The KCs were then washed three times with
PBS and fresh media added (1 mL). Cell culture supernatants and cell
lysates were collected at 1–144 h post-infection at deﬁned time
points. Supernatants were pooled from two sample wells for each
virus and treatment group per time and aliquoted into multiple tubes
for growth kinetics and cytokine analysis. Two new wells were
harvested at each time point due to the cells being collected for cell
counts and gene expression assays (as described below). Super-
natants collected for viral growth kinetics were tested in triplicate.
Samples were stored at −80 °C until analyzed.
Cytokine determination
IL-8, IL-10, RANTES/CCL5 and TNF-α were detected and measured
bymulti-plexedmagnetic bead-based format (Bio-Rad). Supernatants
were not diluted before use, each tested in triplicate, and all assays
were run at high sensitivity (setting on the machine to detect low
concentrations of cytokines in samples) on a Bio-Plex 200 machine
(Bio-Rad). The assay was performed following the manufacturer's
instructions. The cytokine analysis accounted for cell death over time
(represented as observed concentration per live cell in ﬁgures). Cell
viability counts were collected at every time point per virus and
treatment group using trypan blue exclusion.
Gene expression determination
mRNA transcripts for the above cytokines were detected and
measured by a multi-plexed bead-based assay (Panomics, Inc. CA,
now Affymetrix). Probes for targets were designed by Panomics, Inc.
based upon sequence data available from GeneBank. Cell lysates were
collected using the Panomics, Inc. lysis buffer (with proteinase K)
included in the QuantiGene 2.0 Plex kits. Due to limited cell
availability, only one well was used to collect lysate from each virus
and treatment group per time point. All lysates were tested in
triplicate and run at high sensitivity on a Bio-Plex 200 machine (Bio-
Rad). Gene expression data was normalized using housekeeping
genes β-actin and GAPDH (glyceraldehyde-3-phosphate dehydroge-
nase). The data is presented as fold change from control (mock
infected) samples.
Statistical analyses
All growth kinetic, cytokine and gene expression assays reported
here were performed in triplicate. A series of Student's paired t-tests
were used to determine signiﬁcant differences in viral replication,
cytokine production and gene expression. Data was considered
signiﬁcant if pb0.05 (95% conﬁdence interval).Acknowledgments
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